“Regional impact of prophylaxis with the monoclonal antibody palivizumab on ospitalizations from respiratory syncytial virus in infants”, Swiss Med Wkly, vol. 131, no. 1112, pp. 146–151, Mar. 2001, doi: 10.4414/smw.2001.09681.